Brokerages Set Cytokinetics, Incorporated (NASDAQ:CYTK) Target Price at $73.71
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) has been given an average recommendation of “Moderate Buy” by the fifteen ratings firms that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) has been given an average recommendation of “Moderate Buy” by the fifteen ratings firms that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating […]
